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A
 
BSTRACT
 
Tissue eosinophilia is often seen in Hodgkin’s disease
and non-Hodgkin’s lymphoma of T cell lineage. It is,
however, rare in non-Hodgkin’s lymphoma of B cell
origin. We report a case of pulmonary infiltration with
eosinophilia (PIE) syndrome accompanied with non-
Hodgkin’s lymphoma of B cell lineage. A 42-year-old
man with a long-term history of bronchial asthma
consulted the local hospital due to high fever and bilat-
eral cervical lymphadenopathy. He was diagnosed as
having non-Hodgkin’s lymphoma and was referred to
our hospital. Marked blood eosinophilia and infiltra-
tive shadows in both middle lung fields were recog-
nized. After six courses of chemotherapy, including
prednisolone, the shadows were ameliorated, although
cervical lymphadenopathy did not show any regres-
sion, indicating refractory lymphoma. To investigate
pulmonary shadows, we performed transbronchial lung
biopsy and bronchoalveolar lavage (BAL) at the peak
of disease activity before systemic chemotherapy. The
eosinophil recruiting and activating factor interleukin
(IL)-5 was undetectable in both serum and BAL fluid.
Moreover, in the specimen obtained from lung biopsy,
tissue eosinophilia was pathologically recognized, but
IL-5 was not detected by immunohistochemical stain-
ing. These findings indicate that, in this case, any
factors other than IL-5 derived from lymphoma cells
may be concerned with PIE.
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I
 
NTRODUCTION
 
Pulmonary infiltration with eosinophilia (PIE)
 
1
 
 syndrome
is a group of allergic pulmonary disorders. Various
antigens, such as fungi, drugs and parasites, provoke
PIE in a person with an allergic constitution. We report
here a patient with long-term bronchial asthma, who
developed non-Hodgkin’s lymphoma and PIE syndrome.
Six courses of chemotherapy, including prednisolone
(PSL) were performed. Symptoms of asthma were rapidly
improved and abnormal chest shadows were gradually
ameliorated, whereas lymphadenopathy due to non-
Hodgkin’s lymphoma did not regress.
 
C
 
ASE
 
 
 
REPORT
 
Clinical summary
 
A 42-year-old man consulted the local hospital, present-
ing with asthma, high fever and bilateral cervical lympha-
denopathy, in April 1996. He had a long-term history of
recurrent orbital inflammatory pseudotumor and bron-
chial asthma that developed a year before the current
admission. For orbital inflammatory pseudotumor, he
had taken PSL and, in addition, for 4 years before
admission, cyclophosphamide (CPM). Neck lymph node
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biopsy demonstrated non-Hodgkin’s lymphoma, diffuse
mixed, B cell type (Fig. 1a). Therefore, he was referred to
our hospital and admitted on 31 May 1996 (Fig. 2a).
On physical examination, bilateral exophthalmoses and
right blepharoptosis were noted. End-inspiratory fine
crackles were audible in both middle lung fields. Right
parotid, left mandibular, bilateral cervical, right supra-
clavicular and right inguinal lymph nodes were swollen,
but there was no hepatosplenomegaly. The red blood
cell count was 426 × 106 /µL, the hemoglobin concen-
tration was 12.7 g/dL, the white blood cell count was
8100 /µL with 1200 eosinophils/µL and the platelet
count was 19.1 × 104 /µL. There were no remarkable
findings on blood chemistry, except for the serum level
of C-reactive protein (CRP; 2.5 mg/dL). The serum level
of IgE was increased (557.8 IU/mL; normal <165 IU/mL)
without an increase in antigen-specific IgE. Chest
roentgenogram and computed tomography (CT) demon-
strated infiltrations in the bilateral middle lung fields and
swollen lymph nodes in the paratracheal, pretracheal,
subaortic, subcarina and azygos regions (Fig. 2b,c). The
PaO2 and PaCO2 on arterial blood gas analysis were 81
and 43.8 Torr, respectively. Lung function tests indicated
obstructive impairment (% vital capacity (VC) 107.6%;
forced expiratory volume in 1 s (FEV1.0) 53.6%). A purified
protein-derivative test was negative and sputum culture
showed normal flora.
Three weeks after admission, bronchofiberscopy was
performed for further examination of abnormal chest
shadows. At that time, hypereosinophilia was 4100 /µL
and consisted of 39% leukocytes. The bronchial mucosa
was entirely edematous. Transbronchial lung biopsy (TBLB)
was performed from right B4a, B4b, B5a and brocho-
alveolar lavage (BAL) was performed from right B4+5.
Biopsy specimens of TBLB showed involvement of B cell
lymphoma and infiltration of eosinophils (Fig. 1b). In BAL
fluid (BALF), both lymphocytes (28.8%) and eosinophils
(10%) were increased in number. At the peak of disease
activity, eosinophil cationic protein (12.2 µg/L) was
detected in the BALF. Interleukin (IL)-5 was less than
5 pg/mL in both the serum and BALF.
Six courses of chemotherapy, including PSL (1 mg/kg
per day), were performed and the eosinophil count
dropped immediately (Fig. 2a). Thereafter, asthma symp-
toms improved rapidly and abnormal chest shadows
were gradually ameliorated (Fig. 2d). However, lympha-
denopathy due to non-Hodgkin’s lymphoma did not
regress.
DISCUSSION
The PIE syndrome was firstly reported by Löffler in
1932.1 Reeder and Goodrich later used the abbrevia-
tion ‘PIE’ because ‘. . . only pulmonary infiltration and
blood eosinophilia coexisted in all cases’.2 In this case,
a chest roentgenogram on admission demonstrated
infiltrations in both lungs with blood eosinophilia. Chest
CT also showed mediastinal lymphadenopathy and
pulmonary infiltration. A TBLB specimen showed B cell
lymphoma involvement and infiltration of eosinophils
and small lymphocytes. Therefore, the abnormal chest
shadows were thought to be due to both involvement of
Fig. 1 (a) The essential architecture of the lymph node was
destroyed by diffuse infiltration of large or medium-sized lym-
phoma cells (hematoxylin–eosin stain; original magnification
× 100). (b) A transbronchial lung biopsy specimen from right B4
showed involvement of B cell lymphoma and infiltration of eosi-
nophils (hematoxylin–eosin stain; original magnification × 
 
200).
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lymphoma and infiltration of eosinophils. Although cer-
vical lymphadenopathy due to lymphoma did not regress
after chemotherapy including PSL, the shadows were
ameliorated. These findings suggest that these shadows
were due chiefly to eosinophil infiltration. Tissue eosino-
philia is commonly seen in Hodgkin’s disease and non-
Hodgkin’s lymphomas of T cell lineage.3–7 It is less
frequent in non-Hodgkin’s lymphomas of B cell origin.8
In this case, relatively high titers of IgG specific for
Epstein–Barr virus (EBV) capsid antigen (VCA; ×5120;
normal <10) and early antigen (EA)-DR (×640; normal
<10) were noted, but IgM and IgA specific for these
antigens were not increased. Anti-EBV nuclear antigen
(EBNA) antibody was positive with a low titer (×40;
normal <10). Moreover, serum EBV-DNA was positive.
These data indicate that the patient had EBV infection.
Epstein–Barr virus-transformed B lymphocytes have been
shown to produce a potent stimulator of eosinophil
growth and differentiation, namely IL-5.9 We suspected
that IL-5 was most likely a critical factor for eosinophilia
and measured IL-5 in both serum and BALF. Unexpect-
edly, IL-5 was not detected at the peak of disease
activity. Moreover, immunohistochemical staining for
IL-5 was negative in specimens obtained from cervical
lymph node biopsy and TBLB (data not shown). Indeed,
association of IL-5 cannot be completely excluded
because we did not attempt to detect IL-5 before the
peak of blood eosinophilia and pulmonary infiltrations,
but these findings suggest that any factors other than
IL-5 from lymphoma cells may be associated with PIE.
Jundt et al. reported that eotaxin expression correlated
with the extent of tissue eosinophilia in Hodgkin’s
Fig. 2 Clinical course after admission. (a) Six courses of chemotherapy, including prednisolone, were performed and the peri-
pheral blood eosinophil count dropped immediately. (b)
 
 
 
Chest roentgenogram and (c)
 
 
 
computed tomography on admission showed
infiltrative shadows in bilateral middle lung fields and swollen mediastinal lymph nodes. (d)
 
 
 
Infiltrations in bilateral lung fields were
ameliorated on chest roentgenogram at discharge. BAL, bronchoalveolar lavage; TBLB, transbronchial lung biopsy; CHOP, cyclo-
phosphamide/doxorubicin/vincristine/prednisolone; MEPP, mitoxantrone/etoposide/cisplatin/prednisolone; VP-16, etoposide;
ProMACE-CytaBOM, prednisolone/doxorubicin/cyclophosphamide/etoposide/cytarabine/bleomycin/vincristine/methotrexate.
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disease.
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 Teruya-Feldstein 
 
et al
 
. also demonstrated that
interferon-
 
γ
 
-inducible protein 10 (IP-10), monokine
induced by interferon-
 
γ
 
 (Mig) and eotaxin proteins were
localized in the malignant Reed–Sternberg cells and their
variants, as well as to some surrounding inflammatory
cells, by immunohistochemistry.
 
11
 
 Thus, we speculate
some eosinophil chemoattractant factors other than IL-5
may be associated with eosinophilia in our case.
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